Vireo is in early access and completely free until 1 August 2026. Everyone who signs up before then keeps the founding-member price permanently: €3/month (normally €5).
Vireo
/

Charles Ballantyne — CFO

Roles

Hansa Biopharma AB Stockholm
CFO
07.11.2025 – 07.11.2025

Transactions (including via associated entities)

DateIssuerNatureVolumePriceValueSource
07.11.2025Hansa Biopharma AB Stockholm
Bought — open marketAcquisition
25,000USD 2.83
USD 70,853.50
↗